Not Signed In -
Moxifloxacin |
Avelox; moxifloxacin hydrochloride |
Moxifloxacin Systematic (IUPAC) name 1-cyclopropyl-7-[(1S,6S)-2,8-diazabicyclo [4.3.0]non-8-yl]-6-fluoro-8-methoxy-4-oxo- quinoline-3-carboxylic acid Identifiers CAS number 354812-41-2 ATC code J01MA14 PubChem 152946 DrugBank APRD00281 Chemical data Formula C21H24N3FO4 Mol. weight 401.431 g/mol Pharmacokinetic data Bioavailability 86 to 92% Protein binding 30 to 50% Metabolism Glucuronide and sulfate conjugation Cytochrome P450 system not involved ...
Wikipedia - [full article]
Resources
- Avelox (Drug Digest)
- Avelox Consumer Information (U.S. Food and Drug Administration)
Moxifloxacin News Headlines
- Efficacy Of Once-Daily AVELOX(R) In Treating Complicated Intra-Abdominal Infections Highlighted In Two Clinical Data Presentations At ICAAC
MedicalNewsToday - Sat, 30 Sep 2006 07:00 EST
- Avelox As Effective As Multi-dose Combination Therapy For Intra-abdominal Infections
MedicalNewsToday - Sat, 29 Jul 2006 02:00 EST
- Study Shows Once-Daily AVELOX(R) As Effective As Multi-Dose Combination Therapy In Treating Complicated Intra-Abdominal Infections
MedicalNewsToday - Wed, 26 Jul 2006 06:00 EST
- Acute Bacterial Sinusitis - New Study Data Confirm Excellent Speed Of Eradication By Avelox® (moxifloxacin HCl)
MedicalNewsToday - Mon, 29 May 2006 06:00 EST
- Avelox As Effective As Levofloxacin Combination Therapy For Severe Community-acquired Pneumonia
MedicalNewsToday - Wed, 12 Apr 2006 09:00 EST
- Severe Community-Acquired Pneumonia - Avelox(R) Monotherapy As Effective As High-Dose Levofloxacin And Ceftriaxone Combination Therapy
MedicalNewsToday - Sun, 09 Apr 2006 11:00 EST
- Avelox® IV Approved in Europe to Treat Complicated Skin and Skin Structure Infections
MedicalNewsToday - Mon, 25 Jul 2005 11:00 EST
email this page
print this page
bookmark this page
feedback on this page
